Clinical Trials

A High THC Dose Felt Like Psilocybin. The Study Had Four People

A Johns Hopkins pilot reported 25 mg of THC produced a psilocybin-like experience. It enrolled four participants and was funded

Read More

ARPA-H Is Now Funding Ibogaine Trials for Opioid Use Disorder

ARPA-H's ASCENT-IBO program funds Phase 1 and 2 ibogaine trials for opioid use disorder, with patient safety up front. Solution

Read More

A Controlled Trial Finally Tested Ketamine in the Patients Clinics Screen Out

Bipolar patients are routinely screened out of ketamine treatment over mania risk. A midazolam-controlled trial in JAMA Psychiatry finally tested

Read More

6 Regulatory Deadlines Ketamine Clinics Should Have on the Calendar

From FDA's October 5 psychedelics docket to the DEA telehealth expiration and Medicare's 2027 in-person rule, six dates every ketamine

Read More

The American Legion Just Backed a Specific Psychedelics Bill, Not Just the Idea

The American Legion adopted a resolution backing psychedelic therapy for veterans. It endorses S.4220, which would build a VA office

Read More

An MDMA Course Takes 34 Clinician Hours Per Patient

Israeli MDMA trials run 15 sessions over three to four months, including an eight hour dosing day with two therapists

Read More

Psilocybin Protected Nerves From Chemo in Mice. A Non-Hallucinogenic Version Worked Too

A Science paper found psilocybin prevented chemotherapy nerve damage in mice across six treatment cycles. A non-hallucinogenic compound did the

Read More

The DEA Wants Five More Tryptamines in Schedule I. Comments Close October 23

A proposed rule would place five tryptamines into Schedule I. It is the second attempt at the same action, and

Read More

How to Prepare for a Psychedelic Clinical Trial: A Step-by-Step Guide

Want to help the industry understand the potential value of psychedelic therapies? Here's how to prepare for a Psychedelic Clinical

Read More

The Only Two Placebo-Controlled Microdosing Trials Found Nothing

A systematic review screened 897 references on psilocybin microdosing. Of 11 studies, only two were placebo controlled, and neither found

Read More

Explore Psychedelic Therapy Regions